Advertisement
Advertisement
U.S. Markets close in 3 hrs 18 mins
Advertisement
Advertisement
Advertisement
Advertisement

Allarity Therapeutics, Inc. (ALLR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
0.2495-0.0005 (-0.20%)
As of 12:42PM EST. Market open.
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Allarity Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders

    Press release Boston, MA U.S.A. (January 20, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care today announced that the Company’s 2023 Annual Meeting of Stockholders (the “Meeting”), on January 19, 2023, at 1:00 p.m. (Eastern Time) was adjourned without any business being conducted. The Meeting was adjourned until Frid

  • GlobeNewswire

    Allarity Therapeutics Reschedules 2022 Annual Stockholders Meeting and Sets New Record Date

    PRESS RELEASE Boston, MA U.S.A. (December 1, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care, today announced that the Company’s adjourned 2022 Annual Stockholders Meeting (“2022 ASM”) set for December 2, 2022 has been cancelled and a new meeting date for the Annual Stockholders Meeting (“2023 ASM”) will be held, as

  • GlobeNewswire

    Allarity Therapeutics Reports Third Quarter 2022 Financial Results

    Press release Cambridge, MA U.S.A. (November 15, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care today reported financial results for the third quarter ended September 30, 2022. Balance Sheet: As of September 30, 2022, Allarity’s cash was $3.9 million, as compared to $19.6 million as of December 31, 2021. R&D Expense

Advertisement
Advertisement